摘要
Abstract
To uphold the spirit of the 20th National Congress of the Communist Party of China and implement the directives of the Central Committee regarding drug regulation,the 6th China Drug Regulatory Science Conference was held by the China Society for Drug Regulation on April 1,2023,in Beijing.Under the guidance of the National Medical Products Administration and with strong support from relevant units,the conference centered on the theme"New Journey,New Tasks,New Opportunities-Regulatory Science Assists Regulatory Capacity Building and High-Quality Development".Representatives from relevant departments,affiliated units,and 30 provinces(districts,cities),as well as delegates from national pharmaceutical research institutions,universities,medical institutions,pharmaceutical enterprises,and related associations,participated in the conference.Experts engaged in extensive exchanges on topics such as comprehensively improving drug regulatory capabilities,promoting the high-quality development of the pharmaceutical industry,utilizing regulatory science to help build a strong country,providing services to ensure significant achievements in epidemic prevention and control,and building a new pattern of international cooperation.关键词
监管科学/中国式现代化/药品监管/高质量发展Key words
regulatory science/Chinese-style modernization/drug administration,high-quality development分类
医药卫生
